Funder: Breakthrough T1D
Due Dates: January 28, 2026 (Letter of Intent) | March 11, 2026 (Full proposal)
Funding Amounts: Up to $300,000 total for 1 year (including 10% indirect costs for nonprofits); for-profit awards via separate mechanism
Summary: Supports validation and refinement of advanced organoid and organ-on-a-chip platforms for modeling Type 1 Diabetes to accelerate translational research with human-relevant in vitro systems.
Key Information: No deadline extensions; both nonprofit and for-profit entities eligible (see details below).